This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Aernout van Haarst, PhD
Director, Scientific Affairs at Celerion

Profile

Aernout has 25 years of drug development experience at biotechnology companies as well as CROs. This experience includes designing drug development strategies through Proof-of-Concept as well as hands-on experience in the design and conduct of early clinical studies in a breadth of therapeutic areas.

As Director, Scientific Affairs, Aernout is a member of Celerion’s respiratory and vaccine research teams and works closely with external experts in the fields of pulmonology and vaccine development to support drug development programs of Celerion’s clients.


Agenda Sessions

  • Bioanalysis and Pharmacokinetics of Peptides

    16:30
  • Peptide Drug Development; Clinical Pharmacological Considerations

    On Demand